Antinuclear Antibody (ANA) Test Market Size, Share & Trends Analysis Report By Product, By Technique (ELISA, Immunofluorescence Assay), By Application (Rheumatoid Arthritis, SLE), By End Use, And Segment Forecasts, 2018 - 2025

Published: Oct, 2018 | Pages: 110 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global antinuclear antibody test market size is expected to reach USD 2.36 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 12.5% over the forecast period. Rising adoption of ANA test coupled with government initiatives to treat autoimmune disorders is likely to drive the market. Furthermore, rising incidence of autoimmune disorders is projected to fuel the growth.

Antinuclear Antibody (ANA) testing is an important tool to diagnose and manage autoimmune diseases such as Systemic Lupus Erythematosus (SLE) and rheumatoid arthritis. According to the Lupus Foundation of America, at least 5 million people globally and around 1.5 million people in U.S. have a form of lupus. Around 16,000 new cases are registered every year. The disease mostly affects women of childbearing age. SLE accounts for almost 70% of all cases of lupus. The high prevalence of autoimmune disorders is one of the factors driving the market.

Extension of ANA from a test for SLE to a test for any autoimmune diseases has boosted the usage of antinuclear antibody testing. An increase in ANA demand may also be due to the factors such as expanded role of primary care physicians in healthcare delivery systems. In addition, rising R&D activities and government initiatives regarding early diagnosis of autoimmune disorders have triggered the demand for ANA tests.

Further key findings from the study suggest:

• Reagents and assay kits was the largest segment in 2017. It is likely to witness fastest growth over the forecast period due to wide usage and rise in a number of reagent rental agreements

• Immunofluorescence assay led the market in terms of market share in 2017 owing to superior sensitivity compared to other available techniques

• ELISA is expected to be the fastest growing segment over the forecast period. Increasing adoption of these tests is attributed to easy automation and handling without high level of operator skill

• Rheumatoid arthritis segment is projected to hold largest market share, mainly due to high prevalence of the disease

• North America was the largest region in terms of revenue in 2017, followed by Europe. Both are the most well-established regions in terms of the adoption of ANA testing and make up most of the existing market

• Asia Pacific is likely to be the fastest growing region over the forecast period due to unmet clinical needs and need for better diagnosis. Rising government initiatives and clinical research activities for advanced diagnostics are expected to further fuel growth

• Key players operating in the antinuclear antibody test market are Thermo Fisher Scientific Inc.; Alere Inc.; Bio-Rad Laboratories; Trinity Biotech PLC; Zeus Scientific, Inc.; Inova Diagnostics; Immuno Concepts; Erba Diagnostics, Inc.; Euroimmun AG; and Antibodies Inc.

• Key companies are adopting R&D, geographic expansion, and collaborations to gain market share.

 Table of Contents

Chapter 1 Research Methodology & Scope
                   1.1 Information Procurement
                       1.1.1 Purchased database:
                       1.1.2 GVR's internal database
                   1.2 Research Methodology
                   1.3 Geographic Scope & Assumptions
                   1.4 Region-wise Market Calculation
                       1.4.1 Region-wise market: Base estimates
                       1.4.2 Global market: CAGR calculation
                   1.5 Region-based Segment Share Calculation
                   1.6 List of Secondary Sources

Chapter 2 Executive Summary
                   2.1 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Segmentation & Scope
                   3.2 Market Driver Analysis
                       3.2.1 Rising Incidence of autoimmune diseases
                       3.2.2 Growth in number of individuals covered under medical insurance
                       3.2.3 Rising Government Initiatives 
                   3.3 Market restraint analysis
                       3.3.1 Rising concern over reliability of ANA tests
                   3.4 Penetration & growth prospect mapping
                   3.5 ANA Test- SWOT Analysis, By Factor (political & legal, economic and technological)
                   3.6 Industry Analysis - Porter's

Chapter 4 Antinuclear Antibody (ANA) Test Market: Product Outlook
                   4.1 ANA test market by product, movement analysis
                   4.2 Reagents & Assay Kits
                       4.2.1 Reagents & Assay Kits Market estimates and forecast, 2014 - 2025 (USD Million)
                   4.3 Systems
                       4.3.1 Systems Market estimates and forecast, 2014 - 2025 (USD Million)
                   4.4 Software & Services
                       4.4.1 Software & Services Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 5 Antinuclear Antibody (ANA) Test Market: Technique Outlook
                   5.1 ANA test market by technique, movement analysis
                   5.2 ELISA
                       5.2.1 ELISA Market estimates and forecast, 2014 - 2025 (USD Million)
                   5.3 Immunofluorescence Assay
                       5.3.1 Immunofluorescence Assay Market estimates and forecast, 2014 - 2025 (USD Million)
                   5.4 Multiple Assay
                       5.4.1 Multiple Assay Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 6 Antinuclear Antibody (ANA) Test Market: Application Outlook
                   6.1 ANA test market by application, movement analysis
                   6.2 Rheumatoid Arthritis
                       6.2.1 Rheumatoid Arthritis Market estimates and forecast, 2014 - 2025 (USD Million)
                   6.3 Systemic Lupus Erythematosus
                       6.3.1 Systemic Lupus Erythematosus Market estimates and forecast, 2014 - 2025 (USD Million)
                   6.4 Sjogren's Syndrome
                       6.4.1 Sjogren's Syndrome Market estimates and forecast, 2014 - 2025 (USD Million)
                   6.5 Scleroderma
                       6.5.1 Scleroderma Market estimates and forecast, 2014 - 2025 (USD Million)
                   6.6 Others
                       6.6.1 Others Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 7 Antinuclear Antibody (ANA) Test Market: End-use Outlook
                   7.1 ANA test market by end-use, movement analysis
                   7.2 Hospitals
                       7.2.1 Hospitals Market estimates and forecast, 2014 - 2025 (USD Million)
                   7.3 Clinical Laboratories
                       7.3.1 Clinical Laboratories Market estimates and forecast, 2014 - 2025 (USD Million)
                   7.4 Physician Office Laboratories
                       7.4.1 Physician Office Laboratories Market estimates and forecast, 2014 - 2025 (USD Million)
                   7.5 Others
                       7.5.1 Others Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 8 Antinuclear Antibody (ANA) Test Market: Regional Outlook
                   8.1 ANA Test market share by region, 2017 & 2025 (USD Million)
                   8.2 North America
                       8.2.1 North America ANA test market, 2014 - 2025 (USD Million)
                       8.2.2 U.S.
                           8.2.2.1 U.S. ANA test market, 2014 - 2025 (USD Million)
                       8.2.3 Canada
                           8.2.3.1 Canada ANA test market, 2014 - 2025 (USD Million)
                   8.3 Europe
                       8.3.1 Europe ANA test market, 2014 - 2025 (USD Million)
                       8.3.2 U.K.
                           8.3.2.1 U.K. ANA test market, 2014 - 2025 (USD Million)
                       8.3.3 Germany
                           8.3.3.1 Germany ANA test market, 2014 - 2025 (USD Million)
                   8.4 Asia Pacific
                       8.4.1 Asia Pacific ANA test market, 2014 - 2025 (USD Million)
                       8.4.2 Japan
                           8.4.2.1 Japan ANA test market, 2014 - 2025 (USD Million)
                       8.4.3 China
                           8.4.3.1 China ANA test market, 2014 - 2025 (USD Million)
                       8.4.4 India
                           8.4.4.1 India ANA test market, 2014 - 2025 (USD Million)
                   8.5 Latin America
                       8.5.1 Latin America ANA test market, 2014 - 2025 (USD Million)
                       8.5.2 Brazil
                           8.5.2.1 Brazil ANA test market, 2014 - 2025 (USD Million)
                       8.5.3 Mexico
                           8.5.3.1 Mexico ANA test market, 2014 - 2025 (USD Million)
                   8.6 MEA
                       8.6.1 MEA ANA test market, 2014 - 2025 (USD Million)
                       8.6.2 South Africa
                           8.6.2.1 South Africa ANA test market, 2014 - 2025 (USD Million)

Chapter 9 Competitive Landscape
                   9.1 Strategy Framework
                   9.2 Market Participation Categorization
                       9.2.1 Company Profiles
                       9.2.2 Thermo Fisher Scientific, Inc.
                           9.2.2.1 Company Overview
                           9.2.2.2 Financial Performance
                           9.2.2.3 Product Benchmarking
                           9.2.2.4 Strategic Initiatives
                       9.2.3 Alere Inc.
                           9.2.3.1 Company Overview
                           9.2.3.2 Financial Performance
                           9.2.3.3 Product Benchmarking
                           9.2.3.4 Strategic Initiatives
                       9.2.4 Bio-Rad Laboratories, Inc
                           9.2.4.1 Company Overview
                           9.2.4.2 Financial Performance
                           9.2.4.3 Product Benchmarking
                           9.2.4.4 Strategic Initiatives
                       9.2.5 Trinity Biotech PLC
                           9.2.5.1 Company Overview
                           9.2.5.2 Financial Performance
                           9.2.5.3 Product Benchmarking
                           9.2.5.4 Strategic Initiatives
                       9.2.6 Erba Diagnostics, Inc
                           9.2.6.1 Company Overview
                           9.2.6.2 Financial Performance
                           9.2.6.3 Product Benchmarking
                           9.2.6.4 Strategic Initiatives
                       9.2.7 Euroimmun AG
                           9.2.7.1 Company Overview
                           9.2.7.2 Financial Performance
                           9.2.7.3 Product Benchmarking
                           9.2.7.4 Strategic Initiatives
                       9.2.8 Immuno Concepts
                           9.2.8.1 Company Overview
                           9.2.8.2 Financial Performance
                           9.2.8.3 Product Benchmarking
                           9.2.8.4 Strategic Initiatives
                       9.2.9 Inova Diagnostics
                           9.2.9.1 Company Overview
                           9.2.9.2 Financial Performance
                           9.2.9.3 Product Benchmarking
                           9.2.9.4 Strategic Initiatives
                       9.2.10 Zeus Scientific, Inc.
                           9.2.10.1 Company Overview
                           9.2.10.2 Financial Performance
                           9.2.10.3 Product Benchmarking
                           9.2.10.4 Strategic Initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 3 North America ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 4 North America ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 5 North America ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 6 U.S. ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 7 U.S. ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 8 U.S. ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 9 U.S. ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 10 Canada ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 11 Canada ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 12 Canada ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 13 Canada ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 14 Europe ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 15 Europe ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 16 Europe ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 17 Europe ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 18 U.K. ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 19 U.K. ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 20 U.K. ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 21 U.K. ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 22 Germany ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 23 Germany ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 24 Germany ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 25 Germany ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 26 Asia Pacific ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 27 Asia Pacific ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 28 Asia Pacific ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 29 Asia Pacific ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 30 Japan ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 31 Japan ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 32 Japan ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 33 Japan ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 34 China ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 35 China ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 36 China ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 37 China ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 38 India ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 39 India ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 40 India ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 41 India ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 42 Latin America ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 43 Latin America ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 44 Latin America ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 45 Latin America ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 46 Brazil ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 47 Brazil ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 48 Brazil ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 49 Brazil ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 50 Mexico ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 51 Mexico ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 52 Mexico ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 53 Mexico ANA test market estimates and forecasts, by end-use, 2014 - 2025 (USD Million
TABLE 54 MEA ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 55 MEA ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 56 MEA ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 57 MEA ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 58 South Africa ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)
TABLE 59 South Africa ANA test market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 60 South Africa ANA test market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 61 South Africa ANA test market estimates and forecasts, by technique, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain-based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary
FIG. 6 Market trends &outlook
FIG. 7 Market segmentation & scope
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Market restraint relevance analysis (Current & future impact)
FIG. 10 Penetration & growth prospect mapping
FIG. 11 SWOT Analysis, By Factor (political & legal, economic, and technological)
FIG. 12 Porter's Five Forces Analysis
FIG. 13 ANA test market, Product outlook key takeaways
FIG. 14 ANA test market: Product movement analysis
FIG. 15 ANA test market, Technique outlook key takeaways
FIG. 16 ANA test market: Technique movement analysis
FIG. 17 ANA test market, Application outlook key takeaways
FIG. 18 ANA test market: Application movement analysis
FIG. 19 ANA test market, End-use outlook key takeaways
FIG. 20 ANA test market: End-use movement analysis
FIG. 21 Global Reagents & Assay kits market, 2014 - 2025 (USD Million)
FIG. 22 Global Systems market, 2014 - 2025 (USD Million)
FIG. 23 Global Software & Services market, 2014 - 2025 (USD Million)
FIG. 24 Global ELISA market, 2014 - 2025 (USD Million)
FIG. 25 Global Immunofluorescence assay market, 2014 - 2025 (USD Million)
FIG. 26 Global Multiplex assay market, 2014 - 2025 (USD Million)
FIG. 27 Global Rheumatoid Arthritis market, 2014 - 2025 (USD Million)
FIG. 28 Global Systemic Lupus Erythematosus market, 2014 - 2025 (USD Million)
FIG. 29 Global Sjogren's Syndrome market, 2014 - 2025 (USD Million)
FIG. 30 Global Scleroderma market, 2014 - 2025 (USD Million)
FIG. 31 Global Other diseases market, 2014 - 2025 (USD Million)
FIG. 32 Global Hospitals market, 2014 - 2025 (USD Million)
FIG. 33 Global Clinical Laboratories market, 2014 - 2025 (USD Million)
FIG. 34 Global Physician Office Laboratories market, 2014 - 2025 (USD Million)
FIG. 35 Global Others market, 2014 - 2025 (USD Million)
FIG. 36 Regional market place: Key takeaways
FIG. 37 Regional outlook, 2017 & 2025
FIG. 38 North America ANA test market, 2014 - 2025 (USD Million)
FIG. 39 U.S. ANA test market, 2014 - 2025 (USD Million)
FIG. 40 Canada ANA test market, 2014 - 2025 (USD Million)
FIG. 41 Europe ANA test market, 2014 - 2025 (USD Million)
FIG. 42 U.K. ANA test market, 2014 - 2025 (USD Million)
FIG. 43 Germany ANA test market, 2014 - 2025 (USD Million)
FIG. 44 Asia Pacific ANA test market, 2014 - 2025 (USD Million)
FIG. 45 Japan ANA test market, 2014 - 2025 (USD Million)
FIG. 46 China ANA test market, 2014 - 2025 (USD Million)
FIG. 47 India ANA test market, 2014 - 2025 (USD Million)
FIG. 48 Latin America ANA test market, 2014 - 2025 (USD Million)
FIG. 49 Brazil ANA test market, 2014 - 2025 (USD Million)
FIG. 50 Mexico ANA test market, 2014 - 2025 (USD Million)
FIG. 51 MEA ANA test market, 2014 - 2025 (USD Million)
FIG. 52 South Africa ANA test market, 2014 - 2025 (USD Million)
FIG. 53 Strategy framework
FIG. 54 Participant categorization